The following was posted by Donald Forsdyke on mol-evol at net.bio.net, but it
seems quite related also to some of our concerns in metabolic control
analysis:
>The leading article in Nature (15th April) is entitled "WAKE UP CALL FOR
>JAPAN'S GENOMICS". On reading further one finds that it is about genome
>sequencing, NOT genomics.
>Of course, one has to have some sequence before one can begin genomics,
>the latter being the STUDY of sequences, and all that this entails
>(bioinformatic and evolutionary analysis for example). But, HOW MUCH
>SEQUENCE IS ENOUGH?
>The techological imperative seems to have taken over again. Give the guys
>some sequencers and a genome, and they will go on and on until the end,
>and then go about looking for MORE genomes. All this requires megabucks
>whether you count in yen or dollars! How sad that so little of this
>funding employed in doing REAL genomics.
I agree with all that. It seems to me that diverting 1% of the investment
that's going into sequencing into paying people to devise better ways of
using the information that emerges from the sequencing would be very
cost-effective.
Athel
Email: athel at ibsm.cnrs-mrs.fr
Site map: http://ir2lcb.cnrs-mrs.fr/~athel/sitemap.htm
Visegrad, April 1999: http://ir2lcb.cnrs-mrs.fr/~athel/meet99.htm
New Beer in an Old Bottle: http://ir2lcb.cnrs-mrs.fr/~athel/buchner.htm
MCA FAQ: http://ir2lcb.cnrs-mrs.fr/~athel/mcafaq.htm
MCA chapter from my book:
http://ir2lcb.cnrs-mrs.fr/~athel/mcai.htm
---
